Management of retinopathy of prematurity with cryotherapy

Abstract

Purpose. Newborns at risk for retinopathy of prematurity (ROP) should be examined 4 to 8 weeks postpartum. Various treatment modalities including cryotherapy, are proposed to ablate the retinal proliferation, when serious and progressive ROP is detected. This study stresses as main risk factors low birth weight and short gestational age as predisposing to ROP and the efficiency of cryotherapy as a treatment modality.